Clinical Trials Browser

Phase 1/2 × Carcinoma, Non-Small-Cell Lung × Everolimus × Clear all

NCT01427946 2014-11-13

Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung